Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Frontiers in Bioscience (Elite Edition)|January 2, 2013
Hsp10: anatomic distribution, functions, and involvement in human diseaseSabrina David, Fabio Bucchieri, Simona Corrao, et al.
Cancers|June 22, 2023
The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide StudyMarcin Ziętek, Paweł Teterycz, Jędrzej Wierzbicki, et al.
Cancers|May 14, 2022
Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma PatientsPaweł Rogala, Anna M Czarnecka, Bożena Cybulska-Stopa, et al.
Neurologia I Neurochirurgia Polska|January 15, 2025
Recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society and Immuno-oncology Section of Polish Society of Oncology on oncological risk in patients with multiple sclerosis undergoing immunomodulatory therapyIwona Rościszewska-Żukowska, Alina Kułakowska, Alicja Kalinowska, et al.
Journal of Clinical Medicine|April 23, 2022
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World EvidencePaweł Rogala, Anna M Czarnecka, Bożena Cybulska-Stopa, et al.
Immunotherapy|December 23, 2020
First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in PolandBożena Cybulska-Stopa, Renata Pacholczak-Madej, Grażyna Kamińska-Winciorek, et al.
International Journal of Molecular Sciences|February 27, 2026
Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in ChondrosarcomaAgnieszka E Zając, Piotr Rutkowski, Anna Szumera-Ciećkiewicz, et al.
Cancer|March 5, 2020
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupLorenzo D'Ambrosio, Nathan Touati, Jean-Yves Blay, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2024
Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanomaEleanor E Handel, Janet McKeown, Joe Wei, et al.
British Journal of Cancer|August 27, 2022
Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumourTatiana Georgiesh, Ninna Aggerholm-Pedersen, Patrick Schöffski, et al.
Pageof 18